Dyslipidemia is a potentially modifiable cardiovascular risk factor. Whereas the recommendations for the treatment target of dyslipidemia in the general population are being more and more rigorous, the 2013 Kidney Disease: Improving Global Outcomes clinical practice guideline for lipid management in chronic kidney disease (CKD) presented a relatively conservative approach with respect to the indication of lipid lowering therapy and therapeutic monitoring among the patients with CKD. This may be largely attributed to the lack of high-quality evidence derived from CKD population, among whom the overall feature of dyslipidemia is considerably distinctive to that of general population. In this review article, we cover the characteristic features of dyslipidemia and impact of dyslipidemia on cardiovascular outcomes in patients with CKD. We also review the current evidence on lipid lowering therapy to modify the risk of cardiovascular events in this population. We finally discuss the association between dyslipidemia and CKD progression and the potential strategy to delay the progression of CKD in relation to lipid lowering therapy.
Citations
Citations to this article as recorded by
Obesity-related glomerulopathy, A growing kidney burden in the obesity pandemic Mahtab Mashayekhi, Jonathan E. Zuckerman, Sahar H. Koubar, Junnan Wu, Jianbo Qing, Amir Abdipour, Edgar Lerma, Warren Peters, Sayna Norouzi Clinical and Experimental Nephrology.2026; 30(3): 363. CrossRef
Therapeutic potential of S-nitroso-l-cysteine in improving cardiorenal function in eNOS-KO CKD mice Xiaofan Wu, Jiahe Zhao, Zhengqi Xu, Feng Jiang, Moran Wang, Jingwen Tao, Cuntai Zhang, Li Lin, Sheng Li Nitric Oxide.2026; 161: 9. CrossRef
Lipid-Lowering Therapies in Patients with Chronic Kidney Disease: A Perspective on High-Density Lipoprotein Cholesterol Mohammad Abdullah Al Zubair Naim, Keiichi Sumida, Elani Streja, Fridtjof Thomas, Robert Lowell Davis, Kamyar Kalantar-Zadeh, Csaba P. Kovesdy Drugs.2026; 86(2): 177. CrossRef
Dyslipidemia and lipid-lowering therapy in patients on renal replacement therapy: a literature review A. V. Samburov, N. A. Khaibulina, T. L. Kulik, Sh. R. Galeev Russian Journal of Transplantology and Artificial Organs.2026; 27(4): 158. CrossRef
Determinants of circulating PCSK9 levels and the efficacy of PCSK9 inhibitor therapies in chronic kidney disease: a systematic review Tatjana Ábel, Béla Benczúr, Éva Csobod Csajbókné European Journal of Clinical Pharmacology.2026;[Epub] CrossRef
The predictive value of glycated albumin and hemoglobin A1c for all-cause and cardiovascular mortality in chronic kidney disease patients Boshui Huang, Minglong Zheng, Jiaxu Li, Changchang Fang, Yifan Wu, Yao Xiao, Peng Yu, Wenli Gu, Shuxian Zhou, Yuling Zhang, Bo Liu, Xiao Liu, Zhaoyu Liu Diabetology & Metabolic Syndrome.2026;[Epub] CrossRef
Association between non-HDL-cholesterol to HDL-cholesterol ratio (NHHR) and COPD: a cross-sectional study of 11,082 Chinese adults with predictive nomogram development Xiaoli Li, Yunan Wang, Xuanna Zhao BMC Pulmonary Medicine.2026;[Epub] CrossRef
Dyslipidemias in Chronic Kidney Disease: Pathophysiology and Emerging Therapies Irene Martin Capon, Edgar V Lerma, Urmila Anandh, Paolo Nikolai H So, Mohamed Hassanein Indian Journal of Nephrology.2026; 0: 1. CrossRef
Association Between the Triglycerides‐to‐High‐Density Lipoprotein‐Cholesterol (TG/HDL‐C) Ratio and Chronic Kidney Disease: A Systematic Review and Meta‐Analysis of Observational Studies Mansour Bahardoust, Sheida Shokohyar, Ali Delpisheh, Meisam Haghmoradi, Azin Ghaffari Endocrinology, Diabetes & Metabolism.2026;[Epub] CrossRef
Association of Klotho gene polymorphism (rs1207568) and serum miR-192 expression with secondary hyperparathyroidism in Egyptian hemodialysis patients Doaa Mamdouh Aly, Asmaa Mohamed Fteah, Samia El-Shishtawy, Nevine Sherif Egyptian Journal of Medical Human Genetics.2026;[Epub] CrossRef
Integrative omics and experimental validation reveal METTL17 and SLC27A1 as biomarkers and potential therapeutic targets in chronic kidney disease Shiyun Ling, Kaifeng Xie, Penghui Chen, Lichang Liang, Xinyu Shi, Renfa Huang Frontiers in Immunology.2026;[Epub] CrossRef
Atherogenic index of plasma and lower estimated glomerular filtration rate in IgA nephropathy Ricong Xu, Abdul Rashid Qureshi, Mohamed E. Suliman, Nanbo Zhu, Hong Xu, Yuna Chen, Anni Zhong, Qijun Wan, Bengt Lindholm Lipids in Health and Disease.2026;[Epub] CrossRef
The burden of chronic kidney disease attributable to diet low in whole grains from 1990 to 2021: a global, regional and national analysis Zuzhi Zhao, Peng Sun, Zhengshi Xia, Suqin Zhang, Mengfei Xu, Jianhua Li, Pengfei Xu Frontiers in Nutrition.2026;[Epub] CrossRef
Integrated lifestyle management to mitigate MASLD risk in patients with chronic kidney disease: a prospective cohort study Chao Yan, Xinxin Shen, Shaojie Han, Jinzheng He, Tongxu Wang, Xiaobing Gong, Jindong Ding Petersen Journal of Translational Medicine.2026;[Epub] CrossRef
Impact of remnant cholesterol on short-term and long-term prognosis in patients with prediabetes or diabetes undergoing coronary artery bypass grafting: a large-scale cohort study Zhongchen Li, Chunyu Yu, Heng Zhang, Runze Chen, Yan Zhao, Zhe Zheng Cardiovascular Diabetology.2025;[Epub] CrossRef
Effects of Tocotrienol on Cardiovascular Risk Markers in Patients With Chronic Kidney Disease: A Randomized Controlled Trial Liana Trugilho, Lívia Alvarenga, Ludmila Cardozo, Bruna Paiva, Jessyca Brito, Isis Barboza, Jonatas Almeida, Juliana dos Anjos, Pramod Khosla, Marcelo Ribeiro-Alves, Denise Mafra, Eric Gumpricht Journal of Nutrition and Metabolism.2025;[Epub] CrossRef
The Impact of Glomerular Disease on Dyslipidemia in Pediatric Patients Treated with Dialysis Edward Zitnik, Elani Streja, Marciana Laster Nutrients.2025; 17(3): 459. CrossRef
Diabetes, Chronic Kidney Disease, and Vascular Ulcers: Prevention Strategies and Clinical Implications Stefano Mancin, Alfonso Zarrella, Fabio Petrelli, Simone Cosmai, Daniela Cattani, Diego Lopane, Sarah Scollo, Sara Morales Palomares, Marco Sguanci, Antonella Amendola, Giovanni Cangelosi, Beatrice Mazzoleni Diabetology.2025; 6(2): 10. CrossRef
Cardiovascular disease burden and associated risk factors in chronic kidney disease Roshan Bhandari, Srijan Pantha, Ghanashyam Pandey, Richa Paudyal Indian Journal of Medical Sciences.2025; 77: 120. CrossRef
Association of the Triglyceride-Glucose Index with Body Composition and Laboratory Parameters in Chronic Kidney Disease Stages 3–5 Shan-Shan Xu, Yan-Meng Guan, Hong-Yun Xuan, Xiu-Fang Fan, Ping Lu, Li-Hai Hao Risk Management and Healthcare Policy.2025; Volume 18: 903. CrossRef
The association between non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio and pulmonary function: evidence from NHANES 2007–2012 Miaoyan Liu, Chaofeng Gao, Jinggeng Li, Yibo Zhang, Rui Gao, Chaoting Yang, Jian Zhang Frontiers in Nutrition.2025;[Epub] CrossRef
Dietary butyric acid intake, kidney function, and survival: The National Health and Nutrition Examination Surveys, 2005–2018 Wei Tang, Zhengyi Long, Yang Xiao, Jingyun Du, Chenyuan Tang, JunXiang Chen, Can Hou Clinical Nutrition ESPEN.2025; 67: 453. CrossRef
From fat to filter: the effect of adipose tissue-derived signals on kidney function Nermin Ahmed, Carolina Dalmasso, Meghan B. Turner, Gertrude Arthur, Cole Cincinelli, Analia S. Loria Nature Reviews Nephrology.2025; 21(6): 417. CrossRef
CHANGES IN CENTRAL AORTIC PRESSURE AND ARTERIAL STIFFNESS IN YOUNG MEN WITH ARTERIAL HYPERTENSION AND CHRONIC KIDNEY DISEASE O. M. Bilovol, I. I. Kniazkova, V. O. Golovachova, N. V. Kuzminova, D. О. Kіrienko, O. M. Kіrienko, L. P. Abramova World of Medicine and Biology.2025; 21(91): 26. CrossRef
Analysis of the association between long-term exposure to low-dose ionizing radiation and dyslipidemia and its components in medical radiologists: The mediating role of inflammatory markers Changyong Wen, Xiaolian Liu, Yiqing Lian, Weizhen Guo, Lingyu Zhang, Yanting Chen, Xin Lan, Mingfang Li, Sufen Zhang, Weixu Huang, Jianming Zou, Huifeng Chen International Journal of Cardiology Cardiovascular Risk and Prevention.2025; 25: 200406. CrossRef
The protective effect of dietary sphingomyelin supplementation against impaired lipid metabolism in obese mice: a systematic review and meta-analysis of randomized controlled trials Xiao-Yan Qin, Jie Pan, Yi-Na Liu, Hui-Min Luo, Fang Yang Food, Nutrition and Health.2025;[Epub] CrossRef
Non-Traditional Cardiovascular Risk Factors: Tailored Assessment and Clinical Implications Francesco Perone, Marco Bernardi, Luigi Spadafora, Matteo Betti, Stefano Cacciatore, Francesco Saia, Federica Fogacci, Vikash Jaiswal, Elad Asher, Francesco Paneni, Salvatore De Rosa, Maciej Banach, Giuseppe Biondi Zoccai, Pierre Sabouret Journal of Cardiovascular Development and Disease.2025; 12(5): 171. CrossRef
Associations of cardiac biomarkers with chronic kidney disease and mortality in US individuals without prevalent cardiovascular disease Haitao Xie, Shi Wang, Li Qian, Peng Yu, Xiaohu Chen, Shuhua Tang, Le Shen Scientific Reports.2025;[Epub] CrossRef
Accurate Determination of Circulatory Lipids Using a Combination of HILIC-MRM and RPLC-PRM Kyeong-Seog Kim, Jae-Seung Lee, Seung Seok Han, Joo-Youn Cho Analytical Chemistry.2025; 97(18): 9713. CrossRef
Glycemic Control in Patients with Diabetes on Peritoneal Dialysis: From Glucose Sparing Approach to Glucose Monitoring Aleksandra Kezić, Selena Gajić, Ana Račić Ostojić, Ivana Bekić, Ana Bontić, Jelena Pavlović, Marko Baralić, Ljiljana Popović Life.2025; 15(5): 798. CrossRef
Cholesterol and Cardiovascular Risk in Type 2 Diabetes: The Role of Kidney Function Ji-Hyun Kim, Seung-Hwan Lee, Kyu Na Lee, Kyungdo Han, Mee Kyoung Kim Journal of Lipid and Atherosclerosis.2025; 14(2): 190. CrossRef
Understanding Atherosclerotic Plaque Cellular Composition: Recent Advances Driven by Single Cell Omics Esra Cetin, Anne-Catherine Raby Cells.2025; 14(11): 770. CrossRef
Dynamic changes in metabolic syndrome components and chronic kidney disease risk: a population-based prospective cohort study Yue Huang, Rong Fu, Juwei Zhang, Jinsong Zhou, Siting Chen, Zheng Lin, Xiaoxu Xie, Zhijian Hu BMC Endocrine Disorders.2025;[Epub] CrossRef
Causal role of the plasma lipidome in the occurrence and progression of chronic kidney disease: a two-sample Mendelian randomization study Jiaming Su, Jiyuan Hu, Hongfang Liu, Yan Guo, Yang Shi, Yicheng Zheng, Zhaoxi Dong, Jiayou Liu, Zheyu Xu, Xinhui Yu, Jie Mei, Jing Peng, Lin Wang, Qingqing Liu Diabetology & Metabolic Syndrome.2025;[Epub] CrossRef
Suppressing ferroptosis via modulating FTH1 by silybin for treatment of renal fibrosis Jia-Qin Hu, Cang-Qiong Ning, Fang-Cao Pi, Xue-Ni Cai, Jian Zhou, Nan Wang, Li-Li Yu, Hua Zhou, Ying Xie Phytomedicine.2025; 145: 156937. CrossRef
Synergistic Effect of Banaba Leaf Extract and Policosanol (Raydel®) Ameliorate High Cholesterol and High Galactose-Diet Induced Adverse Events in Zebrafish Kyung-Hyun Cho, Sang Hyuk Lee, Yunki Lee, Ashutosh Bahuguna, Ji-Eun Kim, Krismala Djayanti, Cheolmin Jeon Pharmaceuticals.2025; 18(6): 860. CrossRef
Association of Visceral Adiposity with Nephropathy in Patients with Diabetes Mellitus: Data from Chinese and US Cohorts Fan Zhang, Wenjian Li Diabetes, Metabolic Syndrome and Obesity.2025; Volume 18: 1925. CrossRef
Cardiovascular Risk and Its Presentation in Chronic Kidney Disease Stefan J. Schunk, Paul Zimmermann Journal of Clinical Medicine.2025; 14(13): 4567. CrossRef
Prevalence and Correlates of Clinical Nephropathy in Patients With Type 2 Diabetes at Abia State Specialist Hospital and Diagnostic Center, Umuahia, Nigeria: A Cross-Sectional Study Izuchukwu E Okeji, Onyedikachi F Uzor, Christopher C Okafor, Silas U Okafor, Augustine I Airaodion, Obinna J Orji, Isaiah O Abali, Ikpembhosa J Esangbedo, Oladoyin Ogunbayo Jolaoye, Temitayo O Olaotan, Innocent Chima Zacs, Akudo B Umeh, Ugonna Emmanuel Cureus.2025;[Epub] CrossRef
Mitigating Lipotoxicity: A Potential Mechanism to Delay Chronic Kidney Disease Progression Using Current Pharmacological Therapies Suthiya Anumas, Reiko Inagi Nephrology.2025;[Epub] CrossRef
Lipid Accumulation and Insulin Resistance: Bridging Metabolic Dysfunction-Associated Fatty Liver Disease and Chronic Kidney Disease Xinyi Cao, Na Wang, Min Yang, Chun Zhang International Journal of Molecular Sciences.2025; 26(14): 6962. CrossRef
Polyunsaturated fatty acids in kidney diseases: Navigating the fine line between healing and damage Mehrdad Aghasizadeh, Ahmad Reza Bahrami, Maryam M. Matin Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids.2025; 1870(7): 159668. CrossRef
Apitherapy with Royal Jelly and Green Propolis EPP-AF® Improves Cardiovascular Risk Markers in Patients Undergoing Hemodialysis Julie Ann Kemp, Marianna Mendonça, Paloma Chrispim, Marcia Ribeiro, Isadora Britto, Karen S. Coutinho-Wolino, Marcelo Ribeiro-Alves, Lia S. Nakao, Fernanda Kussi, Eduardo B. Coelho, Andresa A. Berretta, Denise Mafra, Ludmila Cardozo Toxins.2025; 17(8): 369. CrossRef
Co-Supplementation of Policosanol and Banaba Leaf Extract Exhibited a Cooperative Effect Against Hyperglycemia and Dyslipidemia in Zebrafish: Highlighting Vital Organ Protection Against High-Cholesterol and High-Galactose Diet Kyung-Hyun Cho, Sang Hyuk Lee, Yunki Lee, Ashutosh Bahuguna, Ji-Eun Kim, Cheolmin Jeon International Journal of Molecular Sciences.2025; 26(16): 7669. CrossRef
Intersecting Pathways of Inflammation, Oxidative Stress, and Atherogenesis in the Evaluation of CKD: Emerging Biomarkers PCSK9, EPHX2, AOPPs, and TBARSs Mohamed-Zakaria Assani, Marius Bogdan Novac, Anda Lorena Dijmărescu, Alexandra-Ștefania Stroe-Ionescu, Mihail Virgil Boldeanu, Isabela Siloși, Lidia Boldeanu Life.2025; 15(8): 1287. CrossRef
Effect of NPB Capsules Consisting of Allium sativum, Hibiscus sabdariffa, Alisma plantago-aquatica, and Gynostemma pentaphyllum on Lipid Metabolism Disorders Hoang L. Hiep, Nguyen H. Ngan, Le H. Phu Tropical Journal of Natural Product Research.2025;[Epub] CrossRef
Impact of Remnant Cholesterol on the Risk for End-Stage Renal Disease in Type 2 Diabetes Mellitus: A Nationwide Population-Based Cohort Study Eun Roh, Ji Hye Heo, Han Na Jung, Kyung-Do Han, Jun Goo Kang, Seong Jin Lee, Sung-Hee Ihm Diabetes & Metabolism Journal.2025; 49(5): 1106. CrossRef
Lipid metabolism in AKI and AKI-CKD transition: Dysregulation, lipotoxicity and therapeutic potential Shuangshuang Wei, Ying Fu, Yuqing Zeng, Wenwen Wu, Juan Cai, Zheng Dong Pharmacology & Therapeutics.2025; 275: 108930. CrossRef
Response to the Letter by Mehta and Sah Regarding Article, Cholesterol and Cardiovascular Risk in Type 2 Diabetes: The Role of Kidney Function Mee Kyoung Kim Journal of Lipid and Atherosclerosis.2025; 14(3): 387. CrossRef
Patterns of lipid profile and genetic variations in South Asians Mahdi Rahmanian Cardiovascular Diabetology – Endocrinology Reports.2025;[Epub] CrossRef
Isolated dyslipidemia triggers early kidney injury through fibrotic remodeling, subcellular lipid accumulation, and AMPK overexpression Mohamed El Fadel Ousmaal, Abderahim Gaceb, Anissa Benali, Jean Giaimis Ultrastructural Pathology.2025; 49(6): 537. CrossRef
Prevalence, predictors, and outcomes of coronary artery disease diagnosed by angiography in live-related kidney transplant candidates Muhammad Abdul Mabood Khalil, Nihal Mohammed Sadagah, Hinda Hassan Khideer Mahmood, Ibtisam Ali Alghamdi, Ghada Abdulrahman Buridi, Ahmed Abdelahad Basha, Alfatih Abdalla Altom, Aileen Jean Dela Cruz, Hitham Abdallah Ahmed Abdallah Ragab, Islam Nabil Elsa BMC Research Notes.2025;[Epub] CrossRef
Stress Pathways in Chronic Kidney Disease: Linking Cortisol, Oxidative Stress, and Inflammation Maria Motrenikova, Krasimir Boyanov, Neli Bojinova, Anelia Bivolarska Antioxidants.2025; 14(10): 1259. CrossRef
Progression in adult patients with early-stage chronic kidney disease attending tertiary hospitals in Dodoma, Tanzania: prospective longitudinal study Denis D Katatwire, Alfred Meremo BMJ Open.2025; 15(11): e094121. CrossRef
Lipid lowering therapies in chronic kidney disease: A call to action Jaime Mazón-Ruiz, David Arroyo, Marina de Cos, María Riestra, Emilio Sánchez-Alvarez, Paula González Bores, Jose Luis Hernández, Pablo Corral Atherosclerosis.2025; 411: 120563. CrossRef
Managing dyslipidemia in chronic kidney disease: a comprehensive overview of evidence and recommendations Ji Yoon Kim, Suk Min Chung, Nam Hoon Kim The Korean Journal of Internal Medicine.2025; 40(6): 876. CrossRef
Direct medical cost analysis in the treatment of chronic kidney disease at Thong Nhat Dong Nai General Hospital in 2024 Tran Ngoc Truong Giang, Tran Nguyen Mai Khanh, Pham Ngoc Bao Vy, Tran Tien An, Tieu Tu Man, Vo Ngoc Yen Nhi Tạp Chí Khoa học Trường Đại học Quốc tế Hồng Bàng.2025; : 11. CrossRef
Trends in Acute Myocardial Infarction Mortality Among Patients With Chronic Kidney Disease in the United States (1999–2024): A CDC WONDER Database Analysis Muhammad Shaheer Bin Faheem, Syed Tawassul Hassan, Syeda Umbreen Munir, Sivaram Neppala, Yasar Sattar, Himaja Dutt Chigurupati, Jamal S. Rana, M. Chadi Alraies Cardiology in Review.2025;[Epub] CrossRef
Chronic kidney disease and cardiovascular risk: Pathophysiology and interventional approaches – systematic review Muhammad Bari Hassan, Sadia Siddique, Sandeep Kumar Maheshwari, Fnu Neelam, Fnu Neha, Bhawna Lohana, Kiran Lohana, Bismillah Athar Dar, Hina Kumari, Raja Pawan, Payal Bai, Sitara Jabeen, Ali Umair, Ali Karim, Zaghum Abbas, Ugal Kishore, Vikram Kumar, Abid Medicine.2025; 104(49): e46189. CrossRef
Association between hemoglobin-to-creatinine ratio and all-cause mortality in patients with coronary artery disease Bo Kang, Chun Zhang, Jie Li, Liang Chen The Egyptian Heart Journal.2025;[Epub] CrossRef
Cuban Sugarcane Wax Alcohol Supplementation Prevents Brain and Eye Damages of Zebrafish Exposed to High-Cholesterol and High-Galactose Diet for 30 Weeks: Protection of Myelin, Cornea, and Retina Kyung-Hyun Cho, Ashutosh Bahuguna, Cheolmin Jeon, Sang Hyuk Lee, Yunki Lee, Seung Hee Baek, Chae-Eun Yang, Ji-Eun Kim, Krismala Djayanti Antioxidants.2025; 14(12): 1453. CrossRef
Epicardial adipose tissue: an overtly concealed contributor to cardiovascular events in chronic kidney disease patients Liqin Cui, Min Yang Lipids in Health and Disease.2025;[Epub] CrossRef
Statin Therapy and Lipid Indices in Chronic Kidney Disease: A Systematic
Review and Meta-analysis of Randomized Control Trials Jafar Karami, Bahman Razi, Danyal Imani, Saeed Aslani, Mahdi Pakjoo, Mahdieh Fasihi, Keyhan Mohammadi, Amirhossein Sahebkar Current Pharmaceutical Design.2024; 30(5): 362. CrossRef
Lipoprotein glomerulopathy with markedly increased arterial stiffness successfully treated with a combination of fenofibrate and losartan: a case report Junichiro Kato, Hideo Okonogi, Go Kanzaki, Haruki Katsumata, Yasuyuki Nakada, Makoto Sagasaki, Kazumasa Komine, Kenji Ito, Takao Saito, Akira Matsunaga, Koh Tokutou, Kazuho Honda, Nobuo Tsuboi, Takashi Yokoo BMC Nephrology.2024;[Epub] CrossRef
Atherogenic index of plasma: a new indicator for assessing the short-term mortality of patients with acute decompensated heart failure Meng Yu, Hongyi Yang, Maobin Kuang, Jiajun Qiu, Changhui Yu, Guobo Xie, Guotai Sheng, Yang Zou Frontiers in Endocrinology.2024;[Epub] CrossRef
Association between lipid accumulation product index and chronic kidney disease: A systematic review and meta-analysis Feixiang Wu, Chenmin Cui, Junping Wu, Yunqing Wang Experimental and Therapeutic Medicine.2024;[Epub] CrossRef
Potential impact of sodium glucose co-transporter (SGLT2) inhibitors on cholesterol fractions in stage 3 chronic kidney disease Rabab Mahmoud Ahmed, Nehal Kamal Rakha, Ahmed Yousry, Amin Roshdy Soliman The Egyptian Journal of Internal Medicine.2024;[Epub] CrossRef
Pulmonary Hypertension in Hemodialysis Patients and Its Determinants: A Hospital Based Cross-Sectional Study Qingfei Yu, Qin Zhang International Journal of General Medicine.2024; Volume 17: 3919. CrossRef
Relationship Between Serum Uromodulin as a Marker of Kidney Damage and Metabolic Status in Patients with Chronic Kidney Disease of Non-Diabetic Etiology Radmila Žeravica, Branislava Ilinčić, Dragan Burić, Ana Jakovljević, Veljko Crnobrnja, Dalibor Ilić, Marija Vukmirović Papuga International Journal of Molecular Sciences.2024; 25(20): 11159. CrossRef
Dyslipidemia in Peritoneal Dialysis: Implications for Peritoneal Membrane Function and Patient Outcomes Natalia Stepanova Biomedicines.2024; 12(10): 2377. CrossRef
Causal associations between kidney function and aortic valve stenosis: a bidirectional Mendelian randomization analysis Wanqian Pan, Le Zhou, Rui Han, Xiaojiao Du, Weixiang Chen, Tingbo Jiang Renal Failure.2024;[Epub] CrossRef
U-shaped association between dietary niacin intake and chronic kidney disease among US elderly: a nationwide cross-sectional study Zhouzhou Xie, Shansen Peng, Gejun Ou, Xiaoqi Zhou, Guihao Zhang, Huiming Jiang, Tianhui Zhang, Nanhui Chen Frontiers in Endocrinology.2024;[Epub] CrossRef
Association between dried fruit intake and kidney function: research from univariate and multivariate Mendelian randomized studies Yuhang Gao, Xinghai Yue, Wanchao Zhao, Fang Yuan Frontiers in Nutrition.2024;[Epub] CrossRef
The Dual Burden: Exploring Cardiovascular Complications in Chronic Kidney Disease Alfredo Caturano, Raffaele Galiero, Maria Rocco, Giuseppina Tagliaferri, Alessia Piacevole, Davide Nilo, Giovanni Di Lorenzo, Celestino Sardu, Vincenzo Russo, Erica Vetrano, Marcellino Monda, Raffaele Marfella, Luca Rinaldi, Ferdinando Carlo Sasso Biomolecules.2024; 14(11): 1393. CrossRef
Association between the EHBP1 SNPs and dyslipidemia in the end-stage renal disease patients with dialysis in Chinese Han population Yan-Fei Lai, Zhong-E Liang, Chun-Xiang Wu, Min Zhang, Zong-Hu Shi, Xiao-Yan Meng, Chun-Xiao Liu Lipids in Health and Disease.2024;[Epub] CrossRef